RU EN

Anfinogenova N.J.

Doctor of Medical Sciences

H-index: RSCI 17, Scopus 16, Web of Science 16

Articles

  1. Kamenshchikov N.O., Podoksenov Yu.K., Anfinogenova Y.J., Kozlov B.N., Svirko Yu.S., Pekarskiy S.E., Evtushenko V.V., Lugovsky V.A., Shipulin V.M., Lomivorotov V.V. Nitric oxide delivery during cardiopulmonary bypass reduces acute kidney injury: A randomized trial. The Journal of Thoracic and Cardiovascular Surgery 2022;163(4):1 393-1 403.
  2. Anfinogenova N.D., Trubacheva I.A., Popov S.V., Efimova E.V., Ussov W.Y. Trends and concerns of potentially inappropriate medication use in patients with cardiovascular diseases. Expert Opinion on Drug Safety 2021;20(10):1 191-1 206.
  3. Anfinogenova N.D., Vasiltseva O.Y., Vrublevsky A.V., Vorozhtsova I.N., Popov S.V., Smorgon A.V., Mochula O.V., Ussov W.Y. Right atrial thrombosis and pulmonary embolism: a narrative review. Seminars in Thrombosis and Hemostasis 2020;46(8):895-907.
  4. Anfinogenova N.D., Quinn M.T., Schepetkin I.A., Atochin D.N. Alarmins and c-Jun N-Terminal Kinase (JNK) Signaling in Neuroinflammation. Cells 2020;9(11):1-25.
  5. Plotnikov M.B., Chernysheva G.A., Smolyakova V.I., Aliev O.I., Trofimova E.S., Sherstoboev E.Y., Osipenko A.N., Khlebnikov A.I., Anfinogenova Ya.J., Schepetkin I.A., Atochin D.N. Neuroprotective Effects of a Novel Inhibitor of c-Jun N-Terminal Kinase in the Rat Model of Transient Focal Cerebral Ischemia. Cells 2020;9(8):1-12.
  6. Plotnikov M.B., Aliev O.I., Shamanaev A.Y., Sidekhmenova A.V., Anishchenko A.M., Fomina T.I., Rydchenko V.S., Khlebnikov A.I., Anfinogenova Y.J., Schepetkin I.A., Atochin D.N. Antihypertensive activity of a new c-Jun N-terminal kinase inhibitor in spontaneously hypertensive rats. Hypertension Research 2020;43:1 068-1 078.
  7. Zavadovsky K.V., Ilyushenkova J.N., Vasiltseva O.Y., Shipulin V.V., Anfinogenova Y.J., Bogdanov Y.I., Boshchenko A.A. Intralobar sequestration associated with the coronary-pulmonary artery fistula from the system of the circumflex artery. Circulation: Cardiovascular Imaging 2020;13(9):1-5.
  8. Ilyushenkova J., Sazonova S., Zavadovsky K., Batalov R., Rogovskaya Y., Anfinogenova Y., Lishmanov Y. Diagnostic efficacy of cardiac scintigraphy with 99mTc-Pyrophosphate for latent myocardial inflammation in patients with fibrillation. Cardiology Research and Practice 2020;2020:1-11.
  9. Plotnikov M.B., Chernysheva G.A., Aliev O.I., Smol'iakova V.I., Fomina T.I., Osipenko A.N., Rydchenko V.S., Anfinogenova Y.J., Khlebnikov A.I., Schepetkin I.A., Atochin D.N. Protective Effects of a New C-Jun N-terminal Kinase Inhibitor in the Model of Global Cerebral Ischemia in Rats. Molecules 2019;24(9):1-23.
  10. Kamenshchikov N.O., Mandel I.A., Podoksenov Yu.K., Svirko Yu.S., Lomivorotov V.V., Mikheev S.L., Kozlov B.N., Shipulin V.M., Nenakhova A.A., Anfinogenova Ya.J. Nitric oxide provides myocardial protection when added to the cardiopulmonary bypass circuit during cardiac surgery: Randomized trial. The Journal of Thoracic and Cardiovascular Surgery 2019;157(6):2 328-2 336.
  11. Anfinogenova Y., Grakova E.V., Shvedova M., Kopieva K.V., Teplyakov A.T., Popov S.V. Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure. Heart Failure Reviews 2018;23:481-497.
  12. Shvedova M., Anfinogenova Y., Atochina-Vasserman E.N., Schepetkin I.A., Atochin D.N. c-Jun N-terminal kinases (JNK) and their inhibitors in myocardial and cerebral ischemia / reperfusion injury. Frontiers in Pharmacology 2018;9:1-17.
  13. Shvedova M., Anfinogenova Y., Popov S.V., Atochin D.N. Connexins and nitric oxide Inside and outside mitochondria: significance for cardiac protection and adaptation. Frontiers in Physiology 2018;9:1-13.
  14. Shchepetkin I., Shvedova M., Anfinogenova Y., Litvak M., Atochin D. Novel targets for positron emission tomography (PET) radiopharmaceutical tracers for visualization of neuroinflammation.. Journal of Physics: Conference Series 2017;886(1):1-5.
  15. Anfinogenova Y., Shvedova M., Popov S.V. Nanoparticles as agents targeting cholesterol crystallization in atherosclerosis. Medical Hypotheses 2017;102:19-22.
  16. Plotnikov M.B., Aliev O.I., Shamanaev A.Y., Sidekhmenova A.V., Anfinogenova Y., Anishchenko A.M., Fomina T.I., Arkhipov A.M. Effects of pentoxifylline on hemodynamic, hemorheological, and microcirculatory parameters in young SHRs during arterial hypertension development. Clinical and Experimental Hypertension 2017;39(6):570-578.
  17. Evtushenko A.V., Evtushenko V.V., Smyshlyaev K.A., Pavlyukova E.N., Vaizov V.K., Katkov V.A., Maximov A.I., Anfinogenova Y. The Transaortic 'Edge-to-Edge' Mitral Valve Plasty in Combined Treatment of Obstructive Cardiomyopathy. Cardiology 2016;134(2):254-255.
  18. Evtushenko V., Smyshlyaev K., Bykov A., Kistenev Yu., Pavlyukova E., Katkov V., Kurlov I., Anfinogenova Y., Evtushenko A. Digital Technologies in Providing Development of Algorithms Surgical Treatment of Supraventricular Arrhythmias. MATEC Web Conf. 2016;79:1-9.
  19. Atochin D.N., Chernysheva G.A., Smolyakova V.I., Osipenko A.N., Logvinov S.V., Zhdankina A.A., Sysolyatin S.V., Kryukov Y.A., Anfinogenova Y, Plotnikova T.M., Plotnikov M.B. Neuroprotective effects of p-tyrosol after the global cerebral ischemia in rats. Phytomedicine 2016;23(7):784-792.
  20. Plotnikov M.B., Aliev O.I., Nosarev A.V., Shamanaev A.Y., Sidekhmenova A.V., Anfinogenova Y., Anishchenko A.M., Pushkina E.V. Relationship between arterial blood pressure and blood viscosity in spontaneously hypertensive rats treated with pentoxifylline. Biorheology 2016;53(2):93-107.
  21. Anfinogenova Y. Vagus nerve stimulation: Invasive or noninvasive?. The Anatolian Journal of Cardiology 2016;16(10):811-812.
  22. Evtushenko A.V., Evtushenko V.V., Bykov A.N., Sergeev V.S., Syryamkin V.I., Kistenev Yu.V., Anfinogenova Y. Physical justification of an increase in the efficacy of radiofrequency systems for myocardial ablation (Conference Paper). Key Engineering Materials 2016;685:432-435.
  23. Afanasiev S.A., Pavliukova E.N., Kuzmichkina M.A., Rebrova T.Yu., Anfinogenova Y., Likhomanov K.S., Karpov R.S. Nonpharmacological Correction of Hypersympatheticotonia in Patients with Chronic Coronary Insufficiency and Severe Left Ventricular Dysfunction. Annals of Noninvasive Electrocardiology 2016;21(6):548-556.
  24. Ripp T.M., Mordovin V.F., Pekarskiy S.E., Ryabova T.R., Zlobina M.V., Baev A.E., Anfinogenova Y., Popov S.V. Predictors of renal denervation efficacy in the treatment of resistant hypertension. Current Hypertension Reports 2015;17(12):1-7.
  25. Suslova T.E., Sitozhevskii A.V., Ogurkova O.N., Kravchenko E.S., Kologrivova I.V., Anfinogenova Y., Karpov R.S. Platelet hemostasis in patients with metabolic syndrome and type 2 diabetes mellitus: cGMP- and NO-dependent mechanisms in the insulin-mediated platelet aggregation. Frontiers in Physiology 2015;5:1-8.
  26. Evtushenko A.V., Evtushenko V.V., Bykov A.N., Sergeev V.S., Syryamkin V.I., Kistenev Yu.V., Anfinogenova Ya.D., Smyshlyaev K.A., Kurlov I.O. Irrigated and Non-irrigated Radiofrequency Ablation Systems and Ways of Non-irrigated RF Systems Development. AIP Conference Proceedings 2015;1688:1-5.
  27. Nosarev A.V., Smagliy L.V., Anfinogenova Y., Popov S.V., Kapilevich L.V. Exercise and NO production: relevance and implication in the cardiopulmonary system. Frontiers in Cell and Developmental Biology 2015;2(73):1-7.
  28. Dyakova E.Y., Kapilevich L.V., Shylko V.G., Popov S.V., Anfinogenova Y. Physical exercise associated with NO production: signaling pathways and significance in health and disease. Frontiers in Cell and Developmental Biology 2015;3(19):1-8.